Skip to content
Home/Companies/TMT/Isto Biologics
IB

Isto Biologics

TMT·US·Active·1yr hold

Isto Biologics is a technology company, headquartered in United States.

Entry
2025
Hold
1yr
Status
Active
Est. EV
–

Who owns Isto Biologics?

Isto Biologics is currently owned by Keensight Capital through Keensight Nova VI (2023 vintage), since 2025.

Hand-verified · updated 2026-04-21

Keensight Capital
Investor
Keensight Capital
Keensight Nova VI · 2023 · Buyout

Key facts

HQUnited States
SectorTechnology

More from Keensight Nova VI

Other portfolio companies in the same fund.

Decision Focus
Active
TMTUK· 2025
Aprovall
Active
TMTFrance· 2024
Octo Telematics
Exited 2014
TMTItaly· 2009
to

More PE-backed in TMT

Comparable tmt deals from other GPs.

1500h
Active
QUANTONATION VENTURESFrance
24ORE
Active
FemuQui VenturesFrance
2Checkout (Avangate)
Exited
Francisco PartnersUS
3878 Best
Active
QUANTONATION VENTURES
3Bee
Active
AgFunderUS
3ma group
Active
Isatis CapitalFrance
Data refreshed weekly · Sourced from public filings